市场调查报告书
商品编码
1370270
除颤器市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测Defibrillators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球除颤器市场规模达到51亿美元。展望未来,IMARC集团预计到2028年市场规模将达到74亿美元,2023-2028年复合年增长率(CAGR)为6.6%。
除颤器是指在危及生命的情况下(例如心室颤动、心律不整和无脉性室性心动过速)向患者心臟提供治疗性电击的医疗设备。它透过向心臟发送电脉衝或衝击波来帮助恢復正常心跳。一些常见类型的去颤器包括自动体外去颤器(AED)、手动/可穿戴式体外除颤器、植入式心律转復除颤器(ICD) 和经静脉或皮下植入式心律转復除颤器。这些设备主要用于医院、诊所、心臟中心、家庭护理机构和院前护理机构。
全球心血管疾病(CVD)和心臟骤停(SCA)盛行率的不断上升是推动市场成长的关键因素之一。此类疾病在老年族群和患有糖尿病、动脉粥状硬化、高血压和中风等其他相关疾病的个体中非常普遍,这促进了已开发国家和新兴国家对产品的采用。此外,医疗中心广泛采用 ICD 也推动了市场成长。现代 ICD 与创新的皮下和经静脉贴片集成,有助于提高患者的整体效率和舒适度。此外,各种技术进步和穿戴式心律转復除颤器 (WCD) 的开发有助于预测 SCA 风险,也对市场成长产生正面影响。其他因素,包括实施促进除颤器培训和认识的优惠政策,以及广泛的研发(R&D)活动和增加政府对医疗保健行业的投资,预计将进一步推动市场。
The global defibrillators market size reached US$ 5.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.
A defibrillator refers to a medical device that delivers a therapeutic shock to the patient's heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia and pulseless ventricular tachycardia. It aids in restoring a normal heartbeat by sending electric pulses or shockwaves to the heart. Some of the common types of defibrillators include automated external defibrillators (AED), manual/wearable external defibrillators, implantable cardioverter defibrillators (ICDs) and transvenous or subcutaneous implantable cardioverter defibrillators. These devices are primarily used in hospitals, clinics, cardiac centers, home care settings and prehospital care settings.
The increasing prevalence of cardiovascular diseases (CVDs) and sudden cardiac arrest (SCA) across the globe is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other related ailments, such as diabetes, atherosclerosis, hypertension and stroke, which is facilitating the product adoption across both the developed and emerging nations. Furthermore, widespread adoption of ICDs across healthcare centers is also providing a boost to the market growth. Modern ICDs are integrated with innovative subcutaneous and transvenous patches that aid in improving the overall efficiency and level of comfort for the patient. Additionally, various technological advancements and the development of wearable cardioverter defibrillators (WCDs) that can aid in predicting the risks of SCAs, are also creating a positive impact on the market growth. Other factors, including the implementation of favorable policies to promote training and awareness regarding defibrillators, along with extensive research and development (R&D) activities and increasing government investments in the healthcare sector, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global defibrillators market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and end-user.
Implantable Defibrillators
Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
External Defibrillators
Manual External Defibrillator
Automated External Defibrillator (AEDs)
Wearable Cardioverter Defibrillator (WCDs)
Hospitals and Clinics
Prehospital Care Settings
Cardiac Centers
Homecare Settings
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Zoll Medical Corporation, Biotronik, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic Inc., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Stryker Corporation, etc.